The discovery that the RNA-cutting enzyme Dicer and its partner BRD4 stabilize human chromosomes points toward a new strategy for cancer therapy.
All in News
The discovery that the RNA-cutting enzyme Dicer and its partner BRD4 stabilize human chromosomes points toward a new strategy for cancer therapy.
FDA approves new treatment for chronic graft-versus-host disease.
Full story at National Cancer Institute
Gut bacteria promote anti-cancer immunity by activating a key innate immune signaling pathway.
A computational network trained to identify faces and other objects uses a surprisingly brain-like strategy to sort it all out.
A new fast-acting insulin inspired by the venom of fish-hunting snails could help people with diabetes better control their blood sugar.
An unusual form of genomic imprinting gives moms and dads different influence over the chemical messengers that control mood and behavior.
Disulfiram prevents the immune system from producing the toxic webs that are thought to drive respiratory distress in patients with life-threatening lung injuries.
Activating a specific acetylcholine receptor in the brain reduces cocaine use in rodents.
A large neuroimaging study has turned up surprisingly few links between white matter structure and reading ability.